Victory Capital Management
VIE

Victory Capital Management’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Victory Capital Management’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,944
Closed -$188K – 3640
2020
Q1 		$188K Buy
+4,944
New +$193K ﹤0.01% 2347

Other funds holding VIE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Victory Capital Management's VIE Position: Q2 2020 in Review

Victory Capital Management sold out of Viela Bio, Inc. Common Stock (VIE) in Q2 2020, closing a stake of 4,944 shares — an estimated $188K sold.

Victory Capital Management first reported a position in VIE in Q1 2020 and held it in 1 quarter. The position peaked at $188K in Q1 2020. 65 funds tracked by Wall St. Rank hold VIE as of Q2 2020.

  • Victory Capital Management reported no remaining Viela Bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 4,944 Viela Bio, Inc. Common Stock shares in Q2 2020, an estimated $188K.
  • Victory Capital Management first reported a position in Viela Bio, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Victory Capital Management's Viela Bio, Inc. Common Stock position peaked at $188K in Q1 2020.
  • 65 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.